Furthermore, these treated cytotoxic CD8+T cells exhibited superior tumor reactivity and in vivo persistence compared to their untreated counterparts when administered as adoptive cell therapy in a murine model of melanoma (90). The gene discussed is CD8A; the disease is melanoma.